...
首页> 外文期刊>Sexuality and disability >The Effectiveness of 'Good-Enough Sex Model' on Sexual Satisfaction and Sexual Intimacy in Women with Multiple Sclerosis: A Randomized Trail
【24h】

The Effectiveness of 'Good-Enough Sex Model' on Sexual Satisfaction and Sexual Intimacy in Women with Multiple Sclerosis: A Randomized Trail

机译:The Effectiveness of 'Good-Enough Sex Model' on Sexual Satisfaction and Sexual Intimacy in Women with Multiple Sclerosis: A Randomized Trail

获取原文
获取原文并翻译 | 示例
           

摘要

Most women with Multiple Sclerosis (MS) suffer from disrupted sexual satisfaction and sexual intimacy. The objective of the current study was to evaluate the effectiveness of a tailored education using the Good-Enough Sex Model (GESM) to enhance the sexual satisfaction and intimacy of women with MS. A parallel randomized trial conducted on a sample of 80 women with a confirmed MS diagnosis in Tehran, Iran. Samples equally were assigned to the intervention and control groups. Accordingly, the intervention group received the educational program in three 90-min sessions. The control group did not receive any education. We used the Index of Sexual Satisfaction and the Sexual Intimacy Scale for collecting data before and one month after the intervention. To analyze the data, independent and paired t-test, Mann-Whitney and Fisher's exact test were applied. The intervention and control groups were similar in demographic and clinical characteristics. The mean age of women in the intervention and control group was 38.35 +/- 5.57 and 36.15 +/- 6.79 years, respectively (p = 0.12). Before the intervention, there was no significant difference in sexual satisfaction and sexual intimacy between the two groups. After the implementation of the GESM education, there was a significant difference between the two groups in sexual satisfaction and sexual intimacy (p = 0.001). The findings showed that the Good-Enough Sex Model is an appropriate educational program for improved sexual satisfaction and sexual intimacy in women who suffer from Multiple Sclerosis. Trial registration: IRCT20150128020854N6. Registered 12 August 2019, .

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号